News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
106 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (21966)
Month
January (3218)
February (3391)
March (3462)
April (3660)
May (4506)
June (2887)
July (2191)
August (2499)
September (2720)
October (3233)
November (3383)
December (2291)
Day
1 (138)
2 (86)
3 (59)
8 (97)
9 (101)
10 (84)
11 (105)
12 (56)
15 (90)
16 (125)
17 (106)
18 (118)
19 (57)
22 (108)
23 (101)
24 (100)
25 (139)
26 (75)
29 (161)
30 (126)
31 (159)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
8
9
10
11
12
15
16
17
18
19
22
23
24
25
26
29
30
31
Press Releases
Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets
July 17, 2024
·
5 min read
Press Releases
Kane Biotech Receives ISO 13485:2016 MDSAP Quality Certification
July 17, 2024
·
3 min read
Press Releases
Dermata Announces Achievement of 50% Enrollment in Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne
July 17, 2024
·
6 min read
Press Releases
FDA Clears Investigational New Drug application for muscular dystrophy treatment from University of Minnesota startup Myogenica
July 17, 2024
·
2 min read
Press Releases
ZILBRYSQTM (zilucoplan injection) Now Approved for Adults with Generalized Myasthenia Gravis (gMG) in Canada
July 17, 2024
·
7 min read
Obesity
Pfizer’s Once-Daily Weight Loss Pill—Good Play or Bad?
After nixing a twice-daily version of its oral GLP-1 agonist, Pfizer is hoping to break into the weight-loss space with a once-daily version, but experts question its outlook.
July 17, 2024
·
4 min read
·
Tyler Patchen
Drug Development
4DMT Unveils More Positive Data for Wet AMD Candidate
Mid-stage data for
4D Molecular Therapeutics’ wet AMD drug 4D-150 show improvements in visual acuity, reduced injection rate and encouraging safety data.
July 17, 2024
·
2 min read
·
Tyler Patchen
Business
Newly Private NGM Bio Raises $122M for Registrational PSC Study
After completing a buyout transaction with The Column Group to remove it from the stock exchange, NGM Bio has raised a $122M Series A to fund a registrational study for a rare liver disease drug and a Phase II trial in hyperemesis gravidarum.
July 17, 2024
·
1 min read
·
Kate Goodwin
Business
Aspen Neuroscience to Present at 2024 Raymond James Biotech Private Company Showcase July 18
July 17, 2024
·
1 min read
FDA
Preliminary data suggests potential use beyond early AKI diagnosis for NGAL biomarker
July 17, 2024
·
4 min read
Previous
8 of 11
Next
